D. Kent Arrell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
D. Kent Arrell has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
A Terzic
Mayo Clinic Center for Regenerative Medicine Rochester Minnesota USA
2 shared publicationsAndre Terzic
Mayo Clinic
2 shared publicationsAbdelaziz Beqqali
1 shared publication- Almudena Martinez-Fernandez
From the Division of Cardiovascular Diseases and Center for Regenerative Medicine, Mayo Clinic, Rochester, MN.
1 shared publication - Andre Terzic
Mayo Clinic
1 shared publication Andrea S. Foulkes
1 shared publication
Latest Publications
- Open Access
- 1 October 2014
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Genetics
- Vol. 7 (5) , 732-3
Delineating RBM20 regulation of alternative splicing in dilated cardiomyopathy.
- 1 October 2014
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Genetics
- Vol. 7 (5) , 732-3
Open AccessDelineating RBM20 regulation of alternative splicing in dilated cardiomyopathy.
- Open Access
- 1 August 2013
- Published by Taylor & Francis in Cell Cycle
- Vol. 12 (15) , 2355-2365
Metabolome and metaboproteome remodeling in nuclear reprogramming
Nuclear reprogramming resets differentiated tissue to generate induced pluripotent stem (iPS) cells. While genomic attributes underlying reacquisition of the embryonic-like state have been delineated, less is known regarding the metabolic dynamics underscoring induction of pluripotency. Metabolomic profiling of fibroblasts vs. iPS cells demonstrated nuclear reprogramming-associated induction of glycolysis, realized through augmented utilization of glucose and accumulation of lactate. Real-time assessment unmasked downregulated mitochondrial reserve capacity and ATP turnover correlating with pluripotent induction. Reduction in oxygen consumption and acceleration of extracellular acidification rates represent high-throughput markers of the transition from oxidative to glycolytic metabolism, characterizing stemness acquisition. The bioenergetic transition was supported by proteome remodeling, whereby 441 proteins were altered between fibroblasts and derived iPS cells. Systems analysis revealed overrepresented canonical pathways and interactome-associated biological processes predicting differential metabolic behavior in response to reprogramming stimuli, including upregulation of glycolysis, purine, arginine, proline, ribonucleoside and ribonucleotide metabolism, and biopolymer and macromolecular catabolism, with concomitant downregulation of oxidative phosphorylation, phosphate metabolism regulation, and precursor biosynthesis processes, prioritizing the impact of energy metabolism within the hierarchy of nuclear reprogramming. Thus, metabolome and metaboproteome remodeling is integral for induction of pluripotency, expanding on the genetic and epigenetic requirements for cell fate manipulation.
- 1 August 2013
- Published by Taylor & Francis in Cell Cycle
- Vol. 12 (15) , 2355-2365
Open AccessMetabolome and metaboproteome remodeling in nuclear reprogramming
Nuclear reprogramming resets differentiated tissue to generate induced pluripotent stem (iPS) cells. While genomic attributes underlying reacquisition of the embryonic-like state have been delineated, less is known regarding the metabolic dynamics underscoring induction of pluripotency. Metabolomic profiling of fibroblasts vs. iPS cells demonstrated nuclear reprogramming-associated induction of glycolysis, realized through augmented utilization of glucose and accumulation of lactate. Real-time assessment unmasked downregulated mitochondrial reserve capacity and ATP turnover correlating with pluripotent induction. Reduction in oxygen consumption and acceleration of extracellular acidification rates represent high-throughput markers of the transition from oxidative to glycolytic metabolism, characterizing stemness acquisition. The bioenergetic transition was supported by proteome remodeling, whereby 441 proteins were altered between fibroblasts and derived iPS cells. Systems analysis revealed overrepresented canonical pathways and interactome-associated biological processes predicting differential metabolic behavior in response to reprogramming stimuli, including upregulation of glycolysis, purine, arginine, proline, ribonucleoside and ribonucleotide metabolism, and biopolymer and macromolecular catabolism, with concomitant downregulation of oxidative phosphorylation, phosphate metabolism regulation, and precursor biosynthesis processes, prioritizing the impact of energy metabolism within the hierarchy of nuclear reprogramming. Thus, metabolome and metaboproteome remodeling is integral for induction of pluripotency, expanding on the genetic and epigenetic requirements for cell fate manipulation.
- 11 February 2013
- Published by Springer Nature in Clinical Pharmacology & Therapeutics
- Vol. 93 (5) , 389-392
Interpreting Networks in Systems Biology
Implementation of network systems biology principles offers unparalleled opportunity to synthesize and integrate inherently complex high‐throughput data for meaningful interpretation. Nonstochastic network templates constructed from extant knowledge facilitate large data set prioritization and prognostication, identifying context‐dependent candidates for follow‐up functional validation and interpretation. In conjunction, enrichment and representation assessment refines comprehension of network‐associated molecular functions and biological processes. Together, exploiting intrinsic network properties provides a value‐added decision‐support instrument for data deconvolution in systems biomedicine.
- 11 February 2013
- Published by Springer Nature in Clinical Pharmacology & Therapeutics
- Vol. 93 (5) , 389-392
Interpreting Networks in Systems Biology
Implementation of network systems biology principles offers unparalleled opportunity to synthesize and integrate inherently complex high‐throughput data for meaningful interpretation. Nonstochastic network templates constructed from extant knowledge facilitate large data set prioritization and prognostication, identifying context‐dependent candidates for follow‐up functional validation and interpretation. In conjunction, enrichment and representation assessment refines comprehension of network‐associated molecular functions and biological processes. Together, exploiting intrinsic network properties provides a value‐added decision‐support instrument for data deconvolution in systems biomedicine.
- 1 August 2012
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Genetics
- Vol. 5 (4) , 478
Systems Proteomics for Translational Network Medicine
Proteomics encompasses diverse methods by which to study proteins, their abundance, structure, posttranslational modifications, and physical or functional interacting partners to map the proteome, the protein complement of a genome. Although such methods can be applied to individual proteins, proteomics facilitates large-scale analysis of complete proteomes or targeted subproteomes (Table 1). Moreover, proteomics enables comparisons between distinct conditions/states, from defined biological sources, across discrete timelines. In general, a proteomic cartography pipeline involves sample acquisition, followed by protein isolation, separation, resolution, and identification (Figure). Along this continuum, each successive module harbors a multistep process, whereby proteomic methodologies can be implemented. Figure. Network systems proteomic pipeline. Strategy extending proteomic profiling from mapping and quantification of protein identities to ontological categorization, pathway analysis and network generation for inclusive systems interpretation. View this table: Table 1. Systems Proteomics Lexicon Once proteins are isolated from the source of interest, 2 major separation strategies have evolved to address proteome complexity.1,2 Traditional gel-based approaches, particularly 2-dimensional gel electrophoresis involving isoelectric focusing followed orthogonally by sodium dodecyl sulfate - polyacrylamide gel electrophoresis, were the earliest methods adopted for protein separation and resolution, comparative assessment of relative abundance, and initial reduction of protein complexity before mass spectrometry (MS). Although 2-dimensional gel electrophoresis remains common, the advent of quantitative MS techniques has led to increased application of various gel-based and gel-free alternatives, whereby protein or peptide complexity is addressed by separation and resolution before or in conjunction with MS, whereas quantification is subsequently measured from MS precursor or fragment ion spectra. Choice of separation strategy is influenced by study objectives and resources, often guided by advantages and limitations to each approach. Quantitative MS methods tend to be less time- and labor-intensive while offering greater potential throughput and data acquisition, yet in instances where 2-dimensional gel electrophoresis approaches are applied in parallel, use of …
- 1 August 2012
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Genetics
- Vol. 5 (4) , 478
Systems Proteomics for Translational Network Medicine
Proteomics encompasses diverse methods by which to study proteins, their abundance, structure, posttranslational modifications, and physical or functional interacting partners to map the proteome, the protein complement of a genome. Although such methods can be applied to individual proteins, proteomics facilitates large-scale analysis of complete proteomes or targeted subproteomes (Table 1). Moreover, proteomics enables comparisons between distinct conditions/states, from defined biological sources, across discrete timelines. In general, a proteomic cartography pipeline involves sample acquisition, followed by protein isolation, separation, resolution, and identification (Figure). Along this continuum, each successive module harbors a multistep process, whereby proteomic methodologies can be implemented. Figure. Network systems proteomic pipeline. Strategy extending proteomic profiling from mapping and quantification of protein identities to ontological categorization, pathway analysis and network generation for inclusive systems interpretation. View this table: Table 1. Systems Proteomics Lexicon Once proteins are isolated from the source of interest, 2 major separation strategies have evolved to address proteome complexity.1,2 Traditional gel-based approaches, particularly 2-dimensional gel electrophoresis involving isoelectric focusing followed orthogonally by sodium dodecyl sulfate - polyacrylamide gel electrophoresis, were the earliest methods adopted for protein separation and resolution, comparative assessment of relative abundance, and initial reduction of protein complexity before mass spectrometry (MS). Although 2-dimensional gel electrophoresis remains common, the advent of quantitative MS techniques has led to increased application of various gel-based and gel-free alternatives, whereby protein or peptide complexity is addressed by separation and resolution before or in conjunction with MS, whereas quantification is subsequently measured from MS precursor or fragment ion spectra. Choice of separation strategy is influenced by study objectives and resources, often guided by advantages and limitations to each approach. Quantitative MS methods tend to be less time- and labor-intensive while offering greater potential throughput and data acquisition, yet in instances where 2-dimensional gel electrophoresis approaches are applied in parallel, use of …
- 2 June 2010
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 88 (1) , 120-125
Network Systems Biology for Drug Discovery
Systems biology provides a platform for integrating multiple components and interactions underlying cell, organ, and organism processes in health and disease. Beyond traditional approaches focused on individual molecules or pathways, bioinformatic network analysis of high-throughput data sets offers an opportunity for integration of biological complexity and multilevel connectivity. Emerging applications in rational drug discovery range from targeting and modeling disease-corrupted networks to screening chemical or ligand libraries to identification/validation of drug-target interactions for improved efficacy and safety.
- 2 June 2010
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 88 (1) , 120-125
Network Systems Biology for Drug Discovery
Systems biology provides a platform for integrating multiple components and interactions underlying cell, organ, and organism processes in health and disease. Beyond traditional approaches focused on individual molecules or pathways, bioinformatic network analysis of high-throughput data sets offers an opportunity for integration of biological complexity and multilevel connectivity. Emerging applications in rational drug discovery range from targeting and modeling disease-corrupted networks to screening chemical or ligand libraries to identification/validation of drug-target interactions for improved efficacy and safety.